Marking the Way for Alzheimer's Drugs

Editor's note: An earlier version of this article incorrectly stated that Eli Lilly purchased two companies from Siemens. The actual transaction was for two tracers used in detecting tau tangles. The video also misidentifies a collaboration between Eli Lilly and General Electric for similar diagnostic products. GE Healthcare is developing a tau tangle imaging test that is independent of Eli Lilly. The Fool regrets the error.

In this video, health care analyst David Williamson discusses Eli Lilly's  (NYSE: LLY  )  recent purchase of two imaging tracers from German conglomerate Siemens. The big pharma currently has Amyvid approved, which detects amyloid brain plaques. Like Amyvid, Eli Lilly is hoping that these tau tangle diagnostics will help both with detection and potentially serve as markers for treatment. Watch and find out how the treatment for Alzheimer's disease is evolving and some potentially groundbreaking drugs in the pipeline.

Is Eli Lilly a buy or sell?
With two of its top three drugs poised to lose patent protection this year, is Eli Lilly a dividend stock headed nowhere fast? In a new premium report, The Motley Fool's senior pharmaceuticals analyst breaks down all of Lilly's moving parts, including an in-depth analysis of the company's must-know opportunities, and reasons to buy and sell today. To find out more, click here to claim your copy today.

Read/Post Comments (1) | Recommend This Article (2)

Comments from our Foolish Readers

Help us keep this a respectfully Foolish area! This is a place for our readers to discuss, debate, and learn more about the Foolish investing topic you read about above. Help us keep it clean and safe. If you believe a comment is abusive or otherwise violates our Fool's Rules, please report it via the Report this Comment Report this Comment icon found on every comment.

Add your comment.

Compare Brokers

Fool Disclosure

Sponsored Links

Leaked: Apple's Next Smart Device
(Warning, it may shock you)
The secret is out... experts are predicting 458 million of these types of devices will be sold per year. 1 hyper-growth company stands to rake in maximum profit - and it's NOT Apple. Show me Apple's new smart gizmo!

DocumentId: 2374482, ~/Articles/ArticleHandler.aspx, 9/29/2016 11:45:21 PM

Report This Comment

Use this area to report a comment that you believe is in violation of the community guidelines. Our team will review the entry and take any appropriate action.

Sending report...

Today's Market

updated 2 hours ago Sponsored by:
DOW 18,143.45 -195.79 -1.07%
S&P 500 2,151.13 -20.24 -0.93%
NASD 5,269.15 -49.39 -0.93%

Create My Watchlist

Go to My Watchlist

You don't seem to be following any stocks yet!

Better investing starts with a watchlist. Now you can create a personalized watchlist and get immediate access to the personalized information you need to make successful investing decisions.

Data delayed up to 5 minutes

Related Tickers

9/29/2016 4:02 PM
LLY $79.74 Down -0.97 -1.20%
Eli Lilly and Co. CAPS Rating: ***
GE $29.53 Down -0.37 -1.24%
General Electric CAPS Rating: ****
MRK $61.91 Down -1.39 -2.20%
Merck and Co. CAPS Rating: ****
SIEGY $114.59 Down -2.96 -2.51%
Siemens AG (ADR) CAPS Rating: ****